GlassScriptPhysician profile
Alamelu Murugappan
NPI 1033219100
$8,844.40
in general payments reported to CMS, 2019-2025
53 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $52.80 · 2021: $1,470 · 2022: $3,518 · 2023: $2,943 · 2024: $119 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,419.06 | 2021-2025 | |
| Ucb, INC. | $960.20 | 2021-2023 | Fintepla, Nayzilam, Briviact |
| Biohaven Pharmaceutical Holding Company LTD. | $387.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $387.10 | 2019-2025 | |
| Eisai INC. | $367.76 | 2021-2025 | |
| Sk Life Science, INC. | $367.74 | 2021-2023 | |
| Amgen INC. | $313.98 | 2019-2023 | Aimovig |
| Jazz Pharmaceuticals INC. | $312.91 | 2022-2023 | |
| Amneal Pharmaceuticals LLC | $291.23 | 2021-2025 | Rytary, Crexont, Lyvispah |
| Lilly USA, LLC | $254.29 | 2019-2023 | Emgality, Reyvow, Amyvid |
| Biogen, INC. | $249.78 | 2021-2022 | |
| Csl Behring | $239.04 | 2022-2023 | Hizentra, Kcentra |
| Avanir Pharmaceuticals, INC. | $219.85 | 2021-2022 | |
| Pfizer INC. | $191.81 | 2023-2025 | |
| Celgene Corporation | $176.71 | 2020-2023 | Zeposia |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alamelu Murugappan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.